2024 HCPCS Code J8670
Rolapitant, oral, 1 mg
| Short Description | Rolapitant, oral, 1mg |
| Product Note | 0211 |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2017 |
| HCPCS Code Added Date | January 01, 2017 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J9316 - Pertuzu, trastuzu, 10 mg
- J9317 - Sacituzumab govitecan-hziy
- J9318 - Inj romidepsin non-lyo 0.1mg
- J9319 - Inj romidepsin lyophil 0.1mg
- J9320 - Streptozocin injection
- J9321 - Inj epcoritamab-bysp 0.16 mg
- J9322 - Inj pemetrexed (bluepoint)
- J9323 - Inj pemetrexed ditromethamin
- J9324 - Inj, pemrydi rtu, 10 mg
- J9325 - Inj talimogene laherparepvec
- J9328 - Temozolomide injection
- J9330 - Temsirolimus injection
- J9331 - Inj sirolimus prot part 1 mg
- J9332 - Inj efgartigimod 2mg
- J9333 - Inj ronzanolixizum-noli 1 mg
- J9334 - Inj efgart-alfa 2mg hya-qvfc
- J9340 - Thiotepa injection
- J9345 - Inj, retifanlimab-dlwr, 1 mg
- J9347 - Inj, tremelimumab-actl, 1 mg
- J9348 - Inj. naxitamab-gqgk, 1 mg